Saudi Arabia is aggressively implementing a national biotechnology strategy aimed at transforming the Kingdom into a global biotech hub. The plan focuses on creating an integrated ecosystem covering vaccine manufacturing, biologics, genomics, and plant biotechnology, aligned with Vision 2030 goals. Regulatory modernization efforts have cut clinical trial approval times by 60%, yielding a 41% year-on-year increase in trials. The government is actively seeking international collaboration to build capacity and advance health equity.